Related Experiment Videos

Considerations for therapy of mixed infections: focus on intraabdominal infection

J T DiPiro1

  • 1University of Georgia College of Pharmacy, Augusta, USA.

Pharmacotherapy
|January 1, 1995
PubMed

Insights

Intraabdominal infections, often caused by multiple bacteria, require surgery and appropriate antimicrobial therapy. Single-agent regimens can be effective, with clinical response guiding treatment adjustments for better patient outcomes.

Area of Science:

  • Infectious Diseases
  • Surgical Infections
  • Microbiology

Background:

  • Intraabdominal infections encompass diverse conditions like appendicitis and peritonitis, frequently involving both aerobic and anaerobic bacteria.
  • While surgery is the primary treatment, antimicrobial administration significantly impacts patient outcomes, including survival and organ function.
  • Evaluating antimicrobial regimens necessitates assessing survival rates, organ failure, drug toxicity, and the risk of superinfections.

Purpose of the Study:

  • To review the principles of antimicrobial therapy for intraabdominal infections.
  • To highlight the importance of selecting effective antimicrobial agents against common pathogens.
  • To emphasize the role of clinical response in guiding antimicrobial treatment adjustments.

Main Methods:

  • Review of existing literature and guidelines on antimicrobial therapy for intraabdominal infections.
  • Analysis of factors influencing patient outcomes in intraabdominal infections.
  • Discussion of evidence supporting single-agent versus combination therapy.

Main Results:

  • Single-agent antimicrobial regimens have shown efficacy in patients with acute intraabdominal contamination and established infections.
  • Antimicrobial effectiveness is determined by activity against the predominant bacteria isolated from the infection site.
  • Guidelines from the Surgical Infection Society provide a framework for selecting appropriate antimicrobial agents.

Conclusions:

  • Effective antimicrobial therapy for intraabdominal infections requires agents active against polymicrobial flora.
  • Patient's clinical response is the most critical factor in directing changes to antimicrobial therapy.
  • Careful consideration of antimicrobial regimens is essential for optimizing outcomes in intraabdominal infections.

Related Concept Videos